MSF welcomes crucial resolution at Globe Wellness Assembly to strengthen countries’ illness testing capacity – Globe

Governments should really now implement the resolution to attain target of enhancing access to testing for all people today

Background:

26 May possibly 2023 – Governments passed a resolution nowadays at the 76th annual Globe Wellness Assembly (WHA) to strengthen countries’ diagnostic testing capacity. The resolution was proposed by Indonesia and governments of the African Area. With practically half of the international population possessing small or no access to testing, Médecins Sans Frontières/Medical doctors Without the need of Borders (MSF) welcomed this resolution as an crucial step towards enhancing international access to diagnostic tools. To guarantee this resolution becomes reality, MSF encourages nations to quickly take the needed methods to implement the resolution: nations should really guarantee that crucial diagnostic tools and tests are cost-effective and accessible nationwide, and assistance regional production of diagnostic tools and tests in low- and middle-earnings nations (LMICs).

Dr Salha Issoufou, Director of Operations for MSF West and Central Africa:

“Ignorance is not bliss when you are dealing with illness outbreaks: timely access to the appropriate testing tools is a single of the most essential components of any healthcare intervention to curb an outbreak and save lives, so it is encouraging to see access to testing getting discussed at a international level.

“We are typically faced with an absence or restricted availability of tests, as there are typically just no tests on the market place that are adapted for the remote, emergency circumstances we operate in. So, we finish up sending samples to far away laboratories, if there are any, which can imply weeks or months of waiting just before finding outcomes. Delays like this can imply delayed responses to outbreaks and lives getting unnecessarily lost, and this is unacceptable. The factor is, it does not have to be this way: the COVID pandemic showed us that fast, effortless-to-use diagnostic tests can be abundantly accessible, as they had been to wealthy nations at the front of the queue. We know it is doable to make tests accessible and accessible, there should really be no double normal in access to lifesaving healthcare testing.

“We urge all governments to make confident absolutely everyone has access to lifesaving tests by swiftly adopting WHO recommendations in national policies, building national crucial diagnostics lists (EDL), and guaranteeing nationwide access to crucial tests for all illnesses relevant to the regional context, like neglected illnesses, and beyond pandemics alone.”

Stijn Deborggraeve, Diagnostics Advisor, MSF Access Campaign:

“We welcome this crucial resolution to strengthen diagnostics capacity, but it will have to not stay just ink on paper. To make it a reality for absolutely everyone, everywhere, we urge all governments to implement the resolution and increase access to diagnostic testing by guaranteeing that good quality-assured tests are cost-effective, and by supporting the regional production of diagnostic tools, specifically in low- and middle-earnings nations.

“Every day we see test shortages in the nations exactly where we operate so it is clear that relying on a handful of multinational diagnostics corporations to meet regional wellness desires is not operating. We want much more effective collaborations involving regional test suppliers and governments, like Brazil’s Bio-Manguinhos, which produces testing tools at non-profit rates to address regional wellness desires. Since, if we hope to increase access to testing for illnesses that mostly influence people today in low- and middle-earnings nations, regional production in these nations is essential.”

——————-

Shailly Gupta
+41-79 203 13 02